menu
    • menu

    Company profile for Xenon Pharmaceuticals Inc

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Xenon is focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. Our goal is to build a self-sustaining, fully-integrated, and profitable company that discovers, develops and commercializes innovative CNS therapeutics, including novel, selective ion channel modulators. We intend to expand our pipeline with therapeutic candidates from our internal research efforts and through ...
    Xenon is focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. Our goal is to build a self-sustaining, fully-integrated, and profitable company that discovers, develops and commercializes innovative CNS therapeutics, including novel, selective ion channel modulators. We intend to expand our pipeline with therapeutic candidates from our internal research efforts and through the acquisition or in-licensing of other technologies or product candidates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Xenon Pharmaceuticals IncCanada Flag
    Country
    Country
    Canada
    Address
    Address
    3650 Gilmore Way Burnaby, BC V5G 4W8
    Telephone
    Telephone
    +6044843300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xenon-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xenon-pharmaceuticals-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xenon To Unveil Azetukalner OLE Study Results In Epilepsy At AES
    Xenon To Unveil Azetukalner OLE Study Results In Epilepsy At AES

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194314/33485/en/Xenon-to-Present-New-Azetukalner-OLE-Study-Data-in-Epilepsy-at-AES-2025.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Xenon To Present at Upcoming Investor Conferences
    Xenon To Present at Upcoming Investor Conferences

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182595/33485/en/Xenon-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Xenon Unveils Q3 2025 Financials And Business Progress
    Xenon Unveils Q3 2025 Financials And Business Progress

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179759/33485/en/Xenon-Reports-Third-Quarter-2025-Financial-Results-Business-Update.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Xenon To Report Q3 2025 Financial Results On November 3, 2025
    Xenon To Report Q3 2025 Financial Results On November 3, 2025

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174585/33485/en/Xenon-to-Report-Q3-2025-Financial-Results-on-November-3-2025.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Xenon Names Tucker Kelly as CFO
    Xenon Names Tucker Kelly as CFO

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3167905/33485/en/Xenon-Announces-Appointment-of-Tucker-Kelly-as-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    Xenon Pharma Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Xenon Pharma Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    07 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/07/3162922/33485/en/Xenon-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    07 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search